Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-27 @ 11:00 PM
Study NCT ID:
NCT00834093
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2009-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
ACTUAL
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-02
First Submit QC Date:
None
Study First Post Date:
2009-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-09
Results First Submit QC Date:
None
Results First Post Date:
2023-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-27
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL